R E Bristow

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi request reprint Ovarian cancer surgery in Maryland: volume-based access to care
    Robert E Bristow
    Department of Biostatistics, Johns Hopkins Oncology Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 93:353-60. 2004
  2. ncbi request reprint Recurrent micropapillary serous ovarian carcinoma
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 1246, USA
    Cancer 95:791-800. 2002
  3. doi request reprint Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis
    Robert E Bristow
    Department of Gynecology, The Kelly Gynecologic Oncology Service, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Gynecol Oncol 112:265-74. 2009
  4. ncbi request reprint Prevention of adhesion formation after radical oophorectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 99:301-8. 2005
  5. ncbi request reprint Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 90:519-28. 2003
  6. ncbi request reprint Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 106:476-81. 2007
  7. ncbi request reprint FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival
    R E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland
    Int J Gynecol Cancer 13:664-72. 2003
  8. ncbi request reprint Centralization of care for patients with advanced-stage ovarian cancer: a cost-effectiveness analysis
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Cancer 109:1513-22. 2007
  9. ncbi request reprint Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 104:480-90. 2007
  10. ncbi request reprint Prevention of adhesion formation after radical hysterectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier: a cost-effectiveness analysis
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Gynecol Oncol 104:739-46. 2007

Detail Information

Publications106 found, 100 shown here

  1. ncbi request reprint Ovarian cancer surgery in Maryland: volume-based access to care
    Robert E Bristow
    Department of Biostatistics, Johns Hopkins Oncology Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 93:353-60. 2004
    ..To characterize the patterns of primary surgical care for ovarian cancer in a statewide population according to annual surgeon and hospital case volume...
  2. ncbi request reprint Recurrent micropapillary serous ovarian carcinoma
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 1246, USA
    Cancer 95:791-800. 2002
    ....
  3. doi request reprint Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis
    Robert E Bristow
    Department of Gynecology, The Kelly Gynecologic Oncology Service, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Gynecol Oncol 112:265-74. 2009
    ..To determine the relative effect of multiple prognostic variables on overall post-recurrence survival time among cohorts of patients with recurrent ovarian cancer undergoing cytoreductive surgery...
  4. ncbi request reprint Prevention of adhesion formation after radical oophorectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 99:301-8. 2005
    ....
  5. ncbi request reprint Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 90:519-28. 2003
    ....
  6. ncbi request reprint Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 106:476-81. 2007
    ..To evaluate the cost-effectiveness of intraperitoneal cisplatin and paclitaxel chemotherapy as front-line treatment for patients with Stage III epithelial ovarian cancer following optimal primary cytoreductive surgery...
  7. ncbi request reprint FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival
    R E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland
    Int J Gynecol Cancer 13:664-72. 2003
    ....
  8. ncbi request reprint Centralization of care for patients with advanced-stage ovarian cancer: a cost-effectiveness analysis
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Cancer 109:1513-22. 2007
    ..The objective of this study was to evaluate the cost-effectiveness of centralized referral of patients with advanced-stage epithelial ovarian cancer who underwent primary cytoreductive surgery and adjuvant chemotherapy...
  9. ncbi request reprint Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 104:480-90. 2007
    ..To summarize the existing data on interval cytoreductive surgery and neoadjuvant chemotherapy as alternative treatment strategies for patients with advanced-stage ovarian cancer...
  10. ncbi request reprint Prevention of adhesion formation after radical hysterectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier: a cost-effectiveness analysis
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Gynecol Oncol 104:739-46. 2007
    ....
  11. ncbi request reprint Impact of surgeon specialty on ovarian-conserving surgery in young females with an adnexal mass
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    J Adolesc Health 39:411-6. 2006
    ....
  12. ncbi request reprint Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 103:1070-6. 2006
    ..To determine the overall survival and relative effect of multiple prognostic variables in cohorts of patients with advanced-stage ovarian cancer treated with platinum-based neoadjuvant chemotherapy in lieu of primary cytoreductive surgery...
  13. ncbi request reprint Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 103:709-13. 2006
    ..To examine the cost-effectiveness of routine vaginal cytology in detecting asymptomatic isolated vaginal recurrence during post-treatment endometrial cancer surveillance...
  14. ncbi request reprint Salvage cytoreductive surgery for recurrent endometrial cancer
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA
    Gynecol Oncol 103:281-7. 2006
    ..To determine the survival impact of salvage cytoreductive surgery, and other prognostic variables, among patients with recurrent endometrial cancer...
  15. ncbi request reprint Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 99:294-300. 2005
    ..To evaluate the utility of combined positron emission tomography/computed tomography (PET/CT) for detecting recurrent epithelial ovarian cancer limited to retroperitoneal adenopathy...
  16. ncbi request reprint Micropapillary serous ovarian carcinoma: surgical management and clinical outcome
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Gynecol Oncol 86:163-70. 2002
    ....
  17. ncbi request reprint Positron emission tomography for detecting clinically occult surgically resectable metastatic ovarian cancer
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institution, Baltimore, Maryland 21287, USA
    Gynecol Oncol 85:196-200. 2002
    ....
  18. ncbi request reprint Endometrial cancer
    R E Bristow
    Department of Gynecology and Obstetrics, The Johns Hopkins Hospital and Medical Institutions, Baltimore, Maryland 21287 1248, USA
    Curr Opin Oncol 11:388-93. 1999
    ..Although uterine papillary serous carcinoma of the endometrium represents only 3% to 4% of endometrial cancer cases, it is of particular interest because of the aggressive clinical course and poor prognosis associated with this disease...
  19. ncbi request reprint Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis
    Robert E Bristow
    Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins Medical Institutions, Baltimore, MD 21287 1248, USA
    J Clin Oncol 20:1248-59. 2002
    ..To evaluate the relative effect of percent maximal cytoreductive surgery and other prognostic variables on survival among cohorts of patients with advanced-stage ovarian carcinoma treated with platinum-based chemotherapy...
  20. ncbi request reprint Ablation of metastatic ovarian carcinoma with the argon beam coagulator: pathologic analysis of tumor destruction
    R E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Gynecol Oncol 83:49-55. 2001
    ....
  21. ncbi request reprint Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator
    R E Bristow
    The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 1248, USA
    Gynecol Oncol 83:39-48. 2001
    ..1-1.0 cm) to microscopic residual disease (complete cytoreduction) among patients with advanced ovarian carcinoma...
  22. ncbi request reprint Surgical standards in the management of ovarian cancer
    R E Bristow
    Department of Gynecology and Obstetrics, The Johns Hopkins Hospital and Medical Institutions, Baltimore, Maryland 21287 1248, USA
    Curr Opin Oncol 12:474-80. 2000
    ....
  23. ncbi request reprint A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography
    R E Bristow
    The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 1248, USA
    Cancer 89:1532-40. 2000
    ..A reliable model for predicting the outcome of primary cytoreductive surgery may be a useful tool in the clinical management of patients with advanced epithelial ovarian carcinoma...
  24. ncbi request reprint Leiomyomatosis peritonealis disseminata and ovarian Brenner tumor associated with tamoxifen use
    R E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 1248, USA
    Int J Gynecol Cancer 11:312-5. 2001
    ..In the setting of continued hormonal treatment for breast carcinoma, the management of leiomyomatosis peritonealis disseminata presents unique clinical challenges...
  25. ncbi request reprint Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease
    R E Bristow
    Department of Gynecology and Obstetrics, Kelly Gynecologic Oncology Service, Baltimore, MD 21287, USA
    Gynecol Oncol 81:279-86. 2001
    ..Pathologic Stage III disease portends a significant risk of distant recurrence. For these patients, administration of adjuvant chemotherapy should be considered in addition to directed RT...
  26. ncbi request reprint The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma
    R E Bristow
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 1248, USA
    Gynecol Oncol 81:92-9. 2001
    ..The aim of this study was to evaluate the survival impact of cytoreductive surgery and other prognostic determinants in patients with Stage IV uterine papillary serous carcinoma (UPSC)...
  27. ncbi request reprint Correlation of extreme drug resistant assay results and progression-free survival following intraperitoneal chemotherapy for advanced ovarian cancer
    A C Pant
    The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
    J Chemother 22:270-4. 2010
    ..Prospective studies, preferably analyzing platinum or taxane EDR individually, are required to validate these observations...
  28. doi request reprint Surveillance for the detection of recurrent ovarian cancer: survival impact or lead-time bias?
    Edward J Tanner
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA
    Gynecol Oncol 117:336-40. 2010
    ....
  29. ncbi request reprint Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma
    A Santillan
    Kelly Gynecology Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Int J Gynecol Cancer 17:601-6. 2007
    ..These observations may help to guide chemotherapeutic decision making in these patients if confirmed in a large-scale study...
  30. ncbi request reprint Feasibility of intravenous gemcitabine and an intraperitoneal platinum agent in the treatment of ovarian cancer
    R L Giuntoli
    Kelly Gynecologic Oncology Service, Department of Gynecology and Onstetrics, Sidney Kimmel Comprehensive Cancer Center, 600 North Wolfe Street, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    J Chemother 23:163-7. 2011
    ..The most common toxicity was myelosuppression, which resulted in dose reductions in almost half of the patients...
  31. ncbi request reprint Ovarian cancer in elderly women
    Nicholas C Lambrou
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Miami, School of Medicine, Miami, Florida, USA
    Oncology (Williston Park) 17:1075-81; discussion 1081, 1085-6, 1091. 2003
    ..In addition, enhanced cooperation between geriatricians and oncologists may assist the pretreatment assessment of elderly patients and improve treatment guidelines in this population...
  32. ncbi request reprint Impact of increasing Papanicolaou test sensitivity and compliance: a modeled cost and outcomes analysis
    F J Montz
    Kelly Gynecologic Oncology Service, The Johns Hopkins Hospital and Medical Institutions, Baltimore, Maryland 21287 1248, USA
    Obstet Gynecol 97:781-8. 2001
    ..To model the impact of increasing screening compliance or implementing liquid-based cytology in populations with known compliance patterns and risk profiles on rates of detection of cervical precancers...
  33. doi request reprint Surgical care of young women diagnosed with ovarian cancer: a population-based perspective
    Edward J Tanner
    Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, USA
    Gynecol Oncol 111:221-5. 2008
    ..To characterize primary surgical care for women with ovarian cancer aged </=50 years versus > 50 years...
  34. ncbi request reprint Predictors of surgical outcome and survival among elderly women diagnosed with ovarian and primary peritoneal cancer
    Hannah H Alphs
    The Johns Hopkins School of Medicine, The Johns Hopkins University, Baltimore, MD 21287, USA
    Gynecol Oncol 103:1048-53. 2006
    ..To identify perioperative variables that will predict surgical outcome and survival among elderly women diagnosed with ovarian and primary peritoneal cancer...
  35. ncbi request reprint A clinical pathway for patients undergoing primary cytoreductive surgery with rectosigmoid colectomy for advanced ovarian and primary peritoneal cancers
    Melissa A Gerardi
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Gynecol Oncol 108:282-6. 2008
    ....
  36. doi request reprint The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Gynecol Oncol 118:262-7. 2010
    ..To examine the effect of hospital procedure volume and other prognostic variables on overall survival outcome and likelihood of receiving standard recommended care among patients with advanced-stage epithelial ovarian cancer...
  37. ncbi request reprint Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcome
    Amer K Karam
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA
    Gynecol Oncol 104:377-80. 2007
    ..We sought to evaluate the impact of TCS on survival and to determine predictors of optimal tertiary resection...
  38. doi request reprint Racial disparities and patterns of ovarian cancer surgical care in California
    F W Liu
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine Medical Center, Orange, CA, USA
    Gynecol Oncol 132:221-6. 2014
    ..To investigate disparities in the frequency of ovarian cancer-related surgical procedures and access to high-volume surgical providers among women undergoing initial surgery for ovarian cancer according to race...
  39. doi request reprint Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States
    B Long
    Department of Obstetrics and Gynecology, University of California at Irvine Medical Center, Orange, CA, USA
    Gynecol Oncol 130:652-9. 2013
    ..The objective of this article is to comprehensively review the scientific literature and summarize the available data regarding the outcome disparities of African American women with uterine cancer...
  40. doi request reprint A retrospective review of the effect of surgeon specialty on the management of 190 benign and malignant pediatric and adolescent adnexal masses
    R N Eskander
    University of California Irvine, Department of Obstetrics and Gynecology, Orange, California, USA
    J Pediatr Adolesc Gynecol 24:282-5. 2011
    ..To investigate the impact of operating surgeon specialty on rates of ovarian preservation, and to explore differences in surgical management when malignant lesions are identified...
  41. ncbi request reprint PET-CT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation
    H K Pannu
    The Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Abdom Imaging 29:398-403. 2004
    ..A trial involving a larger number of patients with a spectrum of disease volumes is necessary to determine the impact of PET-CT in clinical practice...
  42. doi request reprint Racial disparities in surgical care for uterine cancer
    A C Fleury
    Kelly Gynecologic Oncology Service, Johns Hopkins Medical Institutions, 600 N Wolfe Street, Baltimore, MD 21287, USA
    Gynecol Oncol 121:571-6. 2011
    ..To evaluate the association of race and surgical approach for women who underwent surgical treatment for uterine cancer...
  43. ncbi request reprint Psammocarcinoma with an aggressive course
    S H Poggi
    Department of Obstetrics and Gynecology, UCLA School of Medicine, Los Angeles, California 90027, USA
    Obstet Gynecol 92:659-61. 1998
    ..We present this case report of an aggressive course of this disease to alert others that psammocarcinoma may not always follow a benign course...
  44. doi request reprint Imaging uterine cervical cancer with FDG-PET/CT: direct comparison with PET
    Mitsuaki Tatsumi
    Division of Nuclear Medicine, Department of Radiology, Johns Hopkins Medical Institutions, 601 North Caroline Street, Baltimore, MD 21287 0817, USA
    Mol Imaging Biol 11:229-35. 2009
    ....
  45. ncbi request reprint Multidetector CT of peritoneal carcinomatosis from ovarian cancer
    Harpreet K Pannu
    Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins Hospital, 600 N Wolfe St, Baltimore, MD 21287, USA
    Radiographics 23:687-701. 2003
    ..Interactive multiplanar review of the abdomen and pelvis has the potential to improve detection of peritoneal metastases at CT...
  46. ncbi request reprint Argon beam coagulation facilitates management of placenta percreta with bladder invasion
    Amer K Karam
    Department of Gynecology and Obstetrics, The Johns Hopkins Hospital and Medical Institutions, Baltimore, Maryland 21287, USA
    Obstet Gynecol 102:555-6. 2003
    ..Placenta percreta with bladder invasion is a rare but potentially lethal complication of pregnancy...
  47. doi request reprint Transverse colectomy in ovarian cancer surgical cytoreduction: operative technique and clinical outcome
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 NorthWolfe Street, Phipps 281, Baltimore, Maryland 21287, USA
    Gynecol Oncol 109:364-9. 2008
    ..To describe the operative techniques and associated clinical outcomes of patients undergoing transverse colectomy as a component of cytoreductive surgery for advanced or recurrent ovarian cancer...
  48. doi request reprint Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement
    Kara Judson
    Department of Pathology, School of Public Health, The Johns Hopkins University, Baltimore, Maryland, USA
    Int J Gynecol Pathol 27:182-90. 2008
    ....
  49. doi request reprint Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer
    Ritu Salani
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA
    Gynecol Oncol 108:271-5. 2008
    ....
  50. ncbi request reprint Surgical management of mesenteric lymph node metastasis in patients undergoing rectosigmoid colectomy for locally advanced ovarian carcinoma
    Ritu Salani
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 N Wolfe St Phipps 281, Baltimore, Maryland 21224, USA
    Ann Surg Oncol 14:3552-7. 2007
    ....
  51. ncbi request reprint Survival impact of multiple bowel resections in patients undergoing primary cytoreductive surgery for advanced ovarian cancer: a case-control study
    Ritu Salani
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA
    Gynecol Oncol 107:495-9. 2007
    ..To evaluate clinicopathological factors and survival outcome of patients with advanced epithelial ovarian carcinoma undergoing multiple bowel resections to achieve optimal (< or = 1 cm) cytoreduction...
  52. ncbi request reprint Predictors of extended intensive care unit resource utilization following surgery for ovarian cancer
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 107:464-8. 2007
    ....
  53. doi request reprint Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, MD 21287, USA
    Gynecol Oncol 114:173-7. 2009
    ..To describe the operative technique and associated clinical outcomes of patients undergoing rectosigmoid colectomy as a component of secondary cytoreductive surgery for recurrent ovarian cancer...
  54. doi request reprint Cytoreductive surgery for advanced and recurrent endometrial cancer: a review of the literature
    Joyce N Barlin
    Department of Gynecology and Obstetrics, The Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Womens Health (Lond Engl) 5:403-11. 2009
    ....
  55. doi request reprint Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status
    Ritu Salani
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ohio State Medical Center, Columbus, OH 43210, USA
    Am J Obstet Gynecol 200:182.e1-5. 2009
    ..We sought to determine the value of conization margin status in predicting residual and recurrent adenocarcinoma in situ (ACIS) of the cervix...
  56. pmc Impact of surgeon and hospital volume on short-term outcomes and cost of oropharyngeal cancer surgical care
    Christine G Gourin
    Department of Otolaryngology Head and Neck Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Laryngoscope 121:746-52. 2011
    ..To evaluate the impact of surgeon and hospital case volume and other related variables on short-term outcomes after surgery for oropharyngeal cancer...
  57. doi request reprint Volume-based trends in surgical care of patients with oropharyngeal cancer
    Christine G Gourin
    Department of Otolaryngology Head and Neck Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Laryngoscope 121:738-45. 2011
    ..Positive volume-outcome relationships exist for diseases treated with technically complex surgery. Contemporary patterns of oropharyngeal cancer surgery by hospital and surgeon volume are poorly defined...
  58. doi request reprint Surgical technique of diaphragm full-thickness resection and trans-diaphragmatic decompression of pneumothorax during cytoreductive surgery for ovarian cancer
    Shazia Bashir
    The Kelly Gynecology and Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 119:255-8. 2010
    ..To describe the technique and short-term post-operative outcomes associated with diaphragm full-thickness resection (FTR) and intraoperative trans-diaphragmatic decompression of the resultant pneumothorax (TDDP)...
  59. ncbi request reprint Primary insular carcinoid of the ovary
    Teresa P Diaz-Montes
    Department of Gynecology and Obstetrics, The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 101:175-8. 2006
    ..Thus, there appears to be a good correlation between the size of the tumor and the presence of the carcinoid syndrome...
  60. ncbi request reprint Predictive value of endocervical curettage at cervical conization and provider practices in management of high-grade cervical dysplasia
    Joyce N Barlin
    Department of Gynecology and Obstetrics, Johns Hopkins Hospital, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    J Reprod Med 55:129-33. 2010
    ..To determine the utility of endocervical curettage (ECC) at cervical conization for predicting residual or recurrent dysplasia and to evaluate differences in management between general gynecologists and gynecologic oncologists...
  61. doi request reprint Cytoreductive surgery for advanced or recurrent endometrial cancer: a meta-analysis
    Joyce N Barlin
    Department of Gynecology and Obstetrics, The Johns Hopkins Hospital, 600 North Wolfe St, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 118:14-8. 2010
    ..To determine the relative effect and quantify the impact of multiple prognostic variables on median overall survival time among cohorts of patients with advanced or recurrent endometrial cancer undergoing cytoreductive surgery...
  62. doi request reprint Computed tomographic peritoneography prior to intraperitoneal chemotherapy in advanced Müllerian cancer: a pilot study
    Joyce N Barlin
    Department of Gynecology and Obstetrics, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Clin Imaging 34:191-5. 2010
    ..The objective of this study was to utilize computed tomographic peritoneography (CTP) to assess distribution prior to intraperitoneal chemotherapy for advanced müllerian cancer...
  63. doi request reprint Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Departments of Gynecology and Obstetrics and Oncology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 115:334-8. 2009
    ..To evaluate the impact of surgeon and hospital case volume, and other related variables, on short-term outcomes after surgery for ovarian cancer...
  64. doi request reprint Analysis of contemporary trends in access to high-volume ovarian cancer surgical care
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Ann Surg Oncol 16:3422-30. 2009
    ..However, contemporary patterns of primary surgical care for ovarian cancer according to hospital and surgeon case volume remain poorly defined...
  65. ncbi request reprint Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity
    Robert L Giuntoli
    The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, Maryland 21287, USA
    Anticancer Res 29:2875-84. 2009
    ..To identify immunosuppressive elements present in ovarian cancer associated ascites...
  66. ncbi request reprint Concentration of uterine cancer surgical care among the elderly: a population-based perspective
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 107:436-40. 2007
    ..To characterize the primary surgical care and short-term outcomes for uterine cancer in women age > or = 80 years compared to younger women...
  67. ncbi request reprint Endometriosis-associated ovarian carcinoma: differential expression of vascular endothelial growth factor and estrogen/progesterone receptors
    Marcela G del Carmen
    Department of Gynecology and Obstetrics Department of Oncology, The Johns Hopkins Hospital and Medical Institutions, Baltimore, Maryland, USA
    Cancer 98:1658-63. 2003
    ..Using immunohistochemical methods, we compared the differential expression patterns of various cytokines and growth factors in atypical endometriosis (AE) and EAOC...
  68. ncbi request reprint Surgical care of elderly women with ovarian cancer: a population-based perspective
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 99:352-7. 2005
    ..To characterize the primary surgical care and short-term outcomes for ovarian cancer in women aged 80 years and older compared to women younger than 80 years...
  69. ncbi request reprint Combined FDG-positron emission tomography and computed tomography for the detection of ovarian cancer recurrence in an inguinal hernia sac
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 98:510-2. 2005
    ..Combined positron emission tomography (PET) and computed tomography (CT) may have a potential role in the early detection and anatomical localization of recurrent ovarian cancer...
  70. doi request reprint Volume-based trends in thyroid surgery
    Christine G Gourin
    Department of Otolaryngology Head and Neck Surgery, The Johns Hopkins University, 601 N Caroline St, Ste 6260, Baltimore, MD 21287, USA
    Arch Otolaryngol Head Neck Surg 136:1191-8. 2010
    ..to characterize contemporary patterns of thyroid surgical care and variables associated with access to high-volume care...
  71. ncbi request reprint Uterine cancer in Maryland: impact of surgeon case volume and other prognostic factors on short-term mortality
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 103:1043-7. 2006
    ..To characterize the patterns of primary surgical care and short term outcomes for uterine cancer according to surgeon and hospital case volume...
  72. ncbi request reprint Cancer of the uterine corpus among Hispanic women living in the United States: patterns of staging, diagnosis, and primary treatment
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 96:753-9. 2005
    ..To evaluate the demographic characteristics, clinico-pathological features, and patterns of care of uterine cancer among Hispanic women living in the United States...
  73. ncbi request reprint Evaluation and management of adnexal masses during pregnancy
    Robert L Giuntoli
    Hopkins Medical Institutions, Phipps 281, Baltimore, Maryland 21287, USA
    Clin Obstet Gynecol 49:492-505. 2006
    ..In the approximately 5% of cases in which an adnexal masses proves to be a malignancy, appropriate staging may be safely performed. In selected cases, chemotherapy should at least be entertained...
  74. ncbi request reprint Uterine leiomyosarcoma: present management
    Robert L Giuntoli
    The Kelly Gynecologic Oncology Service, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Curr Opin Oncol 16:324-7. 2004
    ..To review current investigations impacting management of uterine leiomyosarcoma (LMS)...
  75. ncbi request reprint Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome
    Ritu Salani
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Cancer 109:685-91. 2007
    ....
  76. ncbi request reprint Clinical significance of Her-2/neu overexpression in uterine serous carcinoma
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Baltimore, MD 21287, USA
    Gynecol Oncol 100:139-44. 2006
    ..To evaluate the clinico-pathologic characteristics and survival outcome associated with overexpression of Her-2/neu in patients with uterine serous carcinoma (USC)...
  77. ncbi request reprint PET-CT in recurrent ovarian cancer: initial observations
    Harpreet K Pannu
    Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 600 N Wolfe St, Baltimore, MD 21287, USA
    Radiographics 24:209-23. 2004
    ..Combined functional-anatomic imaging can also increase diagnostic confidence at CT. Further study is needed to determine the possible benefits of lesion conspicuity at PET and anatomic localization at CT on fused PET-CT scans...
  78. ncbi request reprint Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma
    Robert L Giuntoli
    The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, Maryland 21287, USA
    Gynecol Oncol 106:82-8. 2007
    ..To identify effective treatment options for patients with recurrent uterine leiomyosarcoma (LMS)...
  79. ncbi request reprint A practical framework for patient care teams to prospectively identify and mitigate clinical hazards
    Kurt R Herzer
    Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins University School of Medicine, Baltimore, USA
    Jt Comm J Qual Patient Saf 35:72-81. 2009
    ..Yet, a comprehensive approach by which to safely integrate new therapies into the existing clinical environment has yet to be clearly articulated. Patient care teams can use the proposed framework when introducing new therapies...
  80. ncbi request reprint The role of cytoreductive surgery for colon cancer metastatic to the ovary
    Colleen C McCormick
    Department of Gynecology and Obstetrics, Kelly Gynecologic Oncology Service, The Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Gynecol Oncol 105:791-5. 2007
    ..We sought to further elucidate the survival impact of cytoreductive surgery among patients with colon cancer metastatic to the ovary...
  81. pmc A phase I study of paclitaxel, topotecan, cisplatin and Filgrastim in patients with newly diagnosed advanced ovarian epithelial malignancies: a Gynecologic Oncology Group study
    Deborah K Armstrong
    Johns Hopkins Kimmel Cancer Center, Bunting Blaustein Cancer Research Building, Baltimore, MD 21231 1000, USA
    Gynecol Oncol 105:667-71. 2007
    ....
  82. doi request reprint Volume-based trends in laryngeal cancer surgery
    Christine G Gourin
    Department of Otolaryngology Head and Neck Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Laryngoscope 121:77-84. 2011
    ..Positive volume-outcome relationships exist for diseases treated with technically complex surgery. Contemporary patterns of laryngeal cancer surgery by hospital and surgeon volume are poorly defined...
  83. doi request reprint Analysis of postoperative complications associated with the use of anti-adhesion sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier after cytoreductive surgery for ovarian, fallopian tube and peritoneal cancers
    Lauren S Krill
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 120:220-3. 2011
    ..To evaluate the risk of postoperative complications related to HA-CMC use in patients undergoing optimal cytoreductive surgery for primary and recurrent ovarian, fallopian tube, and peritoneal cancers...
  84. doi request reprint Impact of surgeon and hospital volume on short-term outcomes and cost of laryngeal cancer surgical care
    Christine G Gourin
    Department of Otolaryngology Head and Neck Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Laryngoscope 121:85-90. 2011
    ..To evaluate the impact of surgeon and hospital case volume and other related variables on short-term outcomes after surgery for laryngeal cancer...
  85. ncbi request reprint Management of pelvic hemorrhage
    R S Tomacruz
    Department of Gynecology and Obstetrics The Johns Hopkins Hospital and Medical Institutions, Baltimore, Maryland 21287, USA
    Surg Clin North Am 81:925-48. 2001
    ....
  86. ncbi request reprint Coexistent choriocarcinoma and malignant mixed mesodermal tumor of the uterus
    C P Nguyen
    Department of Gynecology and Obstetrics, The Johns Hopkins Hospital, Baltimore, Maryland 21287, USA
    Gynecol Oncol 79:499-503. 2000
    ..We document the presence of uterine MMMT coexisting with uterine choriocarcinoma that followed an aggressive clinical course and review the possible pathogenesis of this lesion...
  87. ncbi request reprint Metastatic leiomyosarcoma diagnosed after uterine artery embolization
    H E Stohl Posy
    Department of Gynecology and Obstetrics, The Kelly Gynecologic Oncology Service, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Eur J Gynaecol Oncol 30:199-202. 2009
    ..Multiple case reports have described a delay in diagnosis of uterine LMS after UAE. The current case is unique in that it the diagnosis was made based on the presence of a distant metastasis, which occurred years after UAE...
  88. ncbi request reprint Adenocarcinoma in situ and early invasive adenocarcinoma of the uterine cervix
    S D Shipman
    Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Curr Opin Oncol 13:394-8. 2001
    ..Early invasive adenocarcinoma of the uterine cervix is associated with an excellent prognosis, and recent data suggest that radical surgery may be unnecessary...
  89. ncbi request reprint Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients
    Craig C Earle
    Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Natl Cancer Inst 98:172-80. 2006
    ..e., better outcomes). We examined associations between physician specialty and outcomes in a population-based cohort of elderly ovarian cancer surgery patients...
  90. ncbi request reprint Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection
    Deborah Schrag
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Natl Cancer Inst 98:163-71. 2006
    ..e., hospital or surgeon) procedure volumes and patient outcomes have been demonstrated for many types of cancer operation. We performed a population-based cohort study to examine these associations for ovarian cancer resections...
  91. ncbi request reprint Risk of epithelial ovarian cancer recurrence in patients with rising serum CA-125 levels within the normal range
    Antonio Santillan
    Kelly Gynecology Oncology Service, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    J Clin Oncol 23:9338-43. 2005
    ..To evaluate the risk of epithelial ovarian cancer (EOC) recurrence in patients with rising serum cancer antigen 125 (CA-125) levels that remain below the upper limit of normal (< 35 U/mL)...
  92. ncbi request reprint Predicting "unresectable" ovarian cancer: Taking aim at a moving target
    Robert E Bristow
    Gynecol Oncol 100:449-50. 2006
  93. ncbi request reprint Secondary cytoreduction for patients with recurrent ovarian cancer
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Curr Oncol Rep 7:451-8. 2005
    ..A clear understanding of the prognostic factors and expectations from the procedure are necessary in order to identify candidates adequately...
  94. ncbi request reprint Surgery for ovarian cancer: how to improve survival
    Robert E Bristow
    Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Lancet 367:1558-60. 2006
  95. ncbi request reprint Abdominal carcinomatosis in women with a history of breast cancer
    Ruchi Garg
    Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 N Wolfe Street, Baltimore, MD 21287 1281, USA
    Gynecol Oncol 99:65-70. 2005
    ....
  96. doi request reprint Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer
    C William Helm
    Division of Gynecologic Oncology, James Graham Brown Cancer Center, University of Louisville, Kentucky 40207, USA
    J Surg Oncol 98:283-90. 2008
    ....
  97. doi request reprint Feasibility and economic impact of a clinical pathway for pap test utilization in Gynecologic Oncology practice
    Antonio Santillan
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Gynecol Oncol 109:388-93. 2008
    ..S. healthcare system of implementing a clinical pathway for Pap test utilization in screening and surveillance of gynecologic cancers in a university-based gynecologic oncology practice...
  98. ncbi request reprint Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer
    Allison E Axtell
    University of California Los Angeles UCLA Medical Center, Los Angeles, CA, USA
    J Clin Oncol 25:384-9. 2007
    ..Reciprocally cross validate the predictors identified with those from two previously published cohorts from institutions B and C...
  99. ncbi request reprint Gynecologic abnormalities in surgically treated women with stage II or III rectal cancer
    Sven O Becker
    The Kelly Gynecologic Oncology Service, Departments of Gynecology and Obstetrics, The Johns Hopkins Hospital and Medical Institutions, Baltimore, MD 21287, USA
    J Am Coll Surg 194:315-23. 2002
    ..The objective of this article is to review the incidence and management of gynecologic abnormalities in women undergoing surgery for rectal cancer...
  100. ncbi request reprint A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model
    Giovanni D Aletti
    Department of Obstetrics and Gynecology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Gynecol Oncol 107:99-106. 2007
    ..To test the feasibility and utility of a risk-adjusted, multicenter outcomes model for ovarian cancer surgery as a tool for quality improvement...
  101. ncbi request reprint Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer
    Antonio Santillan
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 N Wolfe Street, Phipps 281, Baltimore, MD 21287 1281, USA
    Gynecol Oncol 104:686-90. 2007
    ..To evaluate the feasibility and associated survival outcome of secondary cytoreductive surgery in patients with isolated lymph node recurrence of epithelial ovarian cancer...